The connection between splicing and cancer

Journal of Cell Science

Volumn 119, Issue 13, 2006, Pages 2635-2641

  Srebrow, Anabella ^a   Kornblihtt, Alberto R ^a  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

Author keywords

Alternative splicing; Cancer; Signaling; Splicing

Indexed keywords

BRCA1 PROTEIN; CADHERIN; CIS ACTING ELEMENT; HERMES ANTIGEN; MESSENGER RNA; PROTEIN KINASE LKB1; PROTEIN P53; RAC1 PROTEIN; RAS PROTEIN; REGULATOR PROTEIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ALTERNATIVE RNA SPLICING; BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; EXON; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; GENE MUTATION; HUMAN; INTRON; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE MYELOMA; NOTE; OVARY CANCER; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ANIMALS; HUMANS; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 33746927884     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.03053     Document Type: Note

References (73)

1. Adamia, S., Reiman, T., Crainie, M., Mant, M. J., Belch, A. R. and Pilarski, L. M. (2005). Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma. Blood 105, 4836-4844.
2. Allemand, E., Guil, S., Myers, M., Moscat, J., Caceres, J. F. and Krainer, A. R. (2005). Regulation of heterogenous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shock. Proc. Natl. Acad. Sci. USA 102, 3605-3610.
3. Bartel, F, Taubert, H. and Harris, L. C. (2002). Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell 2, 9-15.
4. Batsche, E., Yaniv, M. and Muchardt, C. (2006). The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat. Struct. Mol. Biol. 13, 22-29.
5. Bentley, D. L. (2005). Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors. Curr. Opin. Cell Biol. 17, 251-256.
6. Black, D. L. (2003). Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72, 291-336.
7. Blaustein, M., Pelisch, F, Coso, O. A., Bissell, M. J., Kornblihtt, A. R. and Srebrow, A. (2004). Mammary epithelia]-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase. J. Biol. Chem. 279, 21029-21037.
8. Blaustein, M., Pelisch, F., Tanos, T., Munoz, M. J., Wengier, D., Quadrana, L., Sanford, J. R., Muschietti, J. P., Kornblihtt, A. R., Caceres, J. F. et al. (2005). Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat. Struct. Mol. Biol. 12, 1037-1044.
9. Bos, J. L. (1989). ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689.
10. Bourdon, J. C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D. P., Saville, M. K. and Lane, D. P. (2005). p53 isoforms can regulate p53 transcriptional activity. Genes Dev. 19, 2122-2137.
11. Brinkman, B. M. (2004). Splice variants as cancer biomarkers. Clin. Biochem. 37, 584-594.
12. Buratti, E., Muro, A. F., Giombi, M., Gherbassi, D., Iaconcig, A. and Baralle, F. E. (2004). RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon. Mol. Cell. Biol. 24, 1387-1400.
13. Caceres, J. F. and Kornblihtt, A. R. (2002). Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet. 18, 186-193.
14. Cartegni, L., Chew, S. L. and Krainer, A. R. (2002). Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285-298.
15. Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q. and Krainer, A. R. (2003). ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31, 3568-3571.
16. Chen, L. L., Sabripour, M., Wu, E. F., Prieto, V. G., Fuller, G. N. and Frazier, M. L. (2005). A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors. Oncogene 24, 4271-4280.
17. Cheng, C. and Sharp, P. A. (2006). Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Mol. Cell. Biol. 26, 362-370.
18. Collesi, C., Santoro, M. M., Gaudino, G. and Comoglio, P. M. (1996). A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. Mol. Cell. Biol. 16, 5518-5526.
19. Di Cristofano, A. and Pandolfi, P. P. (2000). The multiple roles of PTEN in tumor suppression. Cell 100, 387-390.
20. Dreyfuss, G., Matunis, M. J., Pinol-Roma, S. and Burd, C. G. (1993). hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem. 62, 289-321.
21. Egeblad, M. and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174.
22. Faustino, N. A. and Cooper, T. A. (2003). Pre-mRNA splicing and human disease. Genes Dev. 17, 419-437.
23. Ghigna, C., Giordano, S., Shen, H., Benvenuto, F., Castiglioni, F., Comoglio, P. M., Green, M. R., Riva, S. and Biamonti, G. (2005). Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol. Cell 20, 881 -890.
24. Giglio, S., Mancini, F., Gentiletti, F., Sparaco, G., Felicioni, L., Barassi, F., Martella, C., Prodosmo, A., Iacovelli, S., Buttitta, F. et al. (2005). Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization. Cancer Res. 65, 9687-9694.
25. Graveley, B. R. (2000). Sorting out the complexity of SR protein functions. RNA 6, 1197- 1211.
26. Hastings, M. L., Resta, N., Traum, D., Stella, A., Guanti G. and Krainer, A. R. (2005). An LKB1 AT-AC intron mutation causes Peutz-Jeghers syndrome via splicing at noncanonical cryptic splice sites. Nat. Struct. Mal. Biol. 12, 54-59.
27. Huang, Y. and Steitz, J. A. (2005). SRprises along a messenger's journey. Mol. Cell 17, 613-615.
28. Huang, Y., Yario, T. A. and Steitz, J. A. (2004). A molecular link between SR protein dephosphorylation and mRNA export. Proc. Natl. Acad Sci. USA 101, 9666-9670.
29. Konig, H., Ponta, H. and Herrlich, P. (1998). Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J. 17, 2904-2913.
30. Kornblihtt, A. R. (2006). Chromatin, transcript elongation and alternative splicing. Nat. Struct. Mol. Biol. 13,5-7.
31. Kornblihtt, A. R., De La Mata, M., Fededa, J. P., Munoz, M. J. and Nogues, G. (2004). Multiple links between transcription and splicing. RNA 10, 1489-1498.
32. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W. et al. (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921.
33. Li, C., Kato, M., Shine, L., Shively, J. E., Ares, M., Jr and Lin, R. J. (2006). Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays. Cancer Res. 66, 1990-1999.
34. Li, X. and Manley, J. L. (2005). Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 122, 365-378.
35. Lukas, J., Gan, D. Q., Keshmeshian, M., Wen, W. H., Tsao-Wei, D., Rosenberg, S. and Press, M. F. (2001). Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer Res. 61, 3212-3219.
36. Lynch, K. W. (2004). Consequences of regulated pre-mRNA splicing in the immune system. Nat. Rev. Immunol. 4, 931-940.
37. Lynch, K. W. and Weiss, A. (2000). A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras. Mol. Cell. Biol. 20,70-80.
38. Maniatis, T. and Reed, R. (2002). An extensive network of coupling among gene expression machines. Nature 416, 499-506.
39. Manley, J. L. and Tacke, R. (1996). SR proteins and splicing control. Genes Dev. 10, 1569-1579.
40. Matter, N., Herdich, P. and Konig, H. (2002). Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 420, 691-695.
41. Mazoyer, S., Puget, N., Perrin-Vidoz, L., Lynch, H. T., Serova-Sinilnikova, O. M. and Lenoir, G. M. (1998). A BRCA1 nonsense mutation causes exon skipping. Am. J. Hum. Genet. 62, 713-715.
42. Narla, G., Difeo, A., Reeves, H. L., Schaid, D. J., Hirshfeld, J., Hod, E., Katz, A., Isaacs, W. B., Hebbring, S., Komiya, A. et al. (2005). A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res. 65, 1213-1222.
43. Ngo, J. C., Chakrabarti, S., Ding, J. H., Velazquez-Dones, A., Nolen, B., Aubol, B. E., Adams, J. A., Fu, X. D. and Ghosh, G. (2005). Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2. Mol. Cell 20, 77-89.
44. Oren, M. (2003). Decision making by p53: life, death and cancer. Cell Death Differ. 10, 431-442.
45. Pagani, F. and Baralle, F. E. (2004). Genomic variants in exons and introns: identifying the splicing spoilers. Nat. Rev. Genet. 5, 389-396.
46. Patel, N. A., Chalfant, C. E., Watson, J. E., Wyatt, J. R., Dean, N. M., Eichler, D. C. and Cooper, D. R. (2001). Insulin regulates alternative splicing of protein kinase C beta II through a phosphatidylinositol 3-kinase-dependent pathway involving the nuclear serine/arginine-rich splicing factor, SRp4O, in skeletal muscle cells. J. Biol. Chem. 276, 22648-22654.
47. Patel, N. A., Kaneko, S., Apostolatos, H. S., Bae, S. S., Watson, J. E., Davidowitz, K., Chappell, D. S., Birnbaum, M. J., Cheng, J. Q. and Cooper, D. R. (2005). Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40. J. Biol. Chem. 280, 14302-14309.
48. Pelisch, E., Blaustein, M., Kornblihtt, A. R. and Srebrow, A. (2005). Cross-talk between signaling pathways regulates alternative splicing: a novel role for JNK. J. Biol. Chem. 280, 25461-25469.
49. Pettigrew, C., Wayte, N., Lovelock, P. K., Tavtigian, S. V., Chenevix-Trench, G., Spurdle, A. B. and Brown, M. A. (2005). Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms. Breast Cancer Res. 7, R929-R939.
50. Prives, C. and Manfredi, J. J. (2005). The continuing saga of p53 - more sleepless nights ahead. Mol. Cell 19, 719-721.
51. Proudfoot, N. J., Furger, A. and Dye, M. J. (2002). Integrating mRNA processing with transcription. Cell 108, 501-512.
52. Radisky, D. C. (2005). Epithelial-mesenchymal transition. J. Cell Sci. 118, 4325-4326.
53. Radisky, D. C. and Bissell, M. J. (2006). Matrix metalloproteinase-induced genomic instability. Curr. Opin. Genet. Dev. 16, 45-50.
54. Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Nieto, M. A. et al. (2005). Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436, 123-127.
55. Relogio, A., Ben-Dov, C., Baum, M., Ruggiu, M., Gemund, C., Benes, V., Darnell, R. B. and Valcarcel, J. (2005). Alternative splicing microarrays reveal functional expression of neuron-specific regulators in Hodgkin lymphoma cells. J. Biol. Chem. 280, 4779-4784.
56. Rohaly, G., Chemnitz, J., Dehde, S., Nunez, A. M., Heukeshoven, J., Deppert, W. and Dornreiter, I. (2005). A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint. Cell 122, 21-32
57. Scheid, M. P. and Woodgett, J. R. (2001). Phosphatidylinositol 3′ kinase signaling in mammary tumorigenesis. J. Mammary Gland Biol. Neoplasia 6, 83-99.
58. Sharp, P. A. (1994). Split genes and RNA splicing. Cell 77, 805-815.
59. Shin, C. and Manley, J. L. (2004). Cell signalling and the control of pre-mRNA splicing. Nat. Rev. Mol. Cell Biol. 5, 727-738.
60. Singh, A., Karnoub, A. E., Palmby, T. R., Lengyel, E., Sondek, J. and Der, C. J. (2004). Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene 23, 9369-9380.
61. Smith, M. A., Fanger, G. R., O'Connor, L. T., Bridle, P. and Mane, R. A. (1997). Selective regulation of agrin mRNA induction and alternative splicing in PC12 cells by Ras-dependent actions of nerve growth factor. J. Biol. Chem. 272, 15675-15681.
62. Stickeler, E., Kittrell, F., Medina, D. and Berget, S. M. (1999). Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18, 3574-3582.
63. Tarn, W. Y. and Steitz, J. A. (1996). A novel spliceosome containing U11, U12, and U5 snRNPs excises a minor class (AT-AC) intron in vitro. Cell 84, 801-811.
64. Thiery, J. P. and Sleeman, J. P. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131-142.
65. van der Houven van Oordt, W., Diaz-Meco, M. T., Lozano, J., Krainer, A. R., Moscat, J. and Caceres, J. F. (2000). The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J. Cell Biol. 149, 307-316.
66. Venables, J. P. (2004). Aberrant and alternative splicing in cancer. Cancer Res. 64, 7647-7654.
67. Venables, J. P. (2006). Unbalanced alternative splicing and its significance in cancer. BioEssays 28, 378-386.
68. Vivanco, I. and Sawyers, C. L. (2002). The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501.
69. Wang, X. Q., Luk, J. M., Leung, P. P., Wong, B. W., Stanbridge, E. J. and Fan, S. T. (2005). Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma. Clin. Cancer Res. 11, 483-489.
70. Weg-Remers, S., Ponta, H., Herrlich, P. and Konig, H. (2001). Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO J 20, 4194-4203.
71. Weg-Remers, S., Ponta, H., Herrlich, P. and Konig, H. (2002). Antagonistic signaling pathways regulate alternative splicing of CD44 in T cells. Ann. N. Y Acad. Sci. 973, 112-115.
72. Xie, J., Lee, J. A., Kress, T. L., Mowry, K. L. and Black, D. L. (2003). Protein kinase A phosphorylation modulates transport of the polypyrimidine tract-binding protein. Proc. Natl. Acad Sci. USA 100, 8776-8781.
73. Zhou, Y. Q., He, C., Chen, Y. Q., Wang, D. and Wang, M. H. (2003). Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential. Oncogene 22, 186-197.